PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $25 | +127.3% | 6,314 | 0.0% | 0.00% | – |
| Q4 2023 | $11 | +10.0% | 6,314 | 0.0% | 0.00% | – |
| Q3 2023 | $10 | -33.3% | 6,314 | 0.0% | 0.00% | – |
| Q2 2023 | $15 | -21.1% | 6,314 | 0.0% | 0.00% | – |
| Q1 2023 | $19 | +18.8% | 6,314 | 0.0% | 0.00% | – |
| Q4 2022 | $16 | -99.9% | 6,314 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | -5.3% | 6,314 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -67.8% | 6,314 | -46.2% | 0.00% | – |
| Q1 2022 | $59,000 | -48.7% | 11,730 | -31.9% | 0.00% | – |
| Q4 2021 | $115,000 | – | 17,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,304,262 | $5,299,803 | 1.21% |
| STEMPOINT CAPITAL LP | 984,113 | $2,046,955 | 0.60% |
| Velan Capital Investment Management LP | 480,000 | $998,400 | 0.57% |
| CVI Holdings, LLC | 302,746 | $629,712 | 0.54% |
| Privium Fund Management (UK) Ltd | 114,708 | $232,857 | 0.09% |
| Boxer Capital, LLC | 811,627 | $1,688,184 | 0.09% |
| Ikarian Capital, LLC | 180,712 | $375,881 | 0.06% |
| RA Capital Management | 1,900,000 | $3,952,000 | 0.05% |
| Baker Brothers Advisors | 536,832 | $1,116,611 | 0.01% |
| ARMISTICE CAPITAL, LLC | 520,000 | $1,081,600 | 0.01% |